Medical Device Electronic Labeling Act

Hozzl · 2025-03-18T14:03:03Z

Explore the details of House Bill 1539 Medical Device Electronic Labeling Act currently in Congress. Get insights into its purpose, current status, sponsors, and potential impact on Health. Stay informed on legislative developments.

3/18/2025, 2:03 PM

Summary of Bill HR 1539

Bill 119 hr 1539, also known as the "Electronic Labeling Expansion Act," aims to amend the Federal Food, Drug, and Cosmetic Act to allow for certain medical devices to have their required labeling made available solely through electronic means. This bill seeks to modernize the way in which information about medical devices is provided to consumers and healthcare professionals.

The bill would expand the types of devices that can utilize electronic labeling, which would allow for more efficient and cost-effective distribution of information. This would also help to reduce the environmental impact of traditional paper labeling.

Proponents of the bill argue that electronic labeling would provide more up-to-date and easily accessible information about medical devices, ultimately leading to better patient outcomes. However, critics have raised concerns about potential accessibility issues for those who may not have access to electronic devices. Overall, the Electronic Labeling Expansion Act aims to bring the regulation of medical device labeling into the digital age, with the goal of improving transparency and efficiency in the healthcare industry.

Congressional Summary of HR 1539

Medical Device Electronic Labeling Act

This bill expands the permitted use of electronic labeling of medical devices to allow directions for use and warning labels for all medical devices to be provided electronically, rather than physically (i.e., affixed to or accompanying the device or its container).

(Under current law, direction and warning labels may be provided electronically only for (1) prescription devices intended for use in health care facilities or by health care professionals, and (2) in vitro diagnostic devices intended for use in blood establishments or by health care professionals.)

Under the bill, direction and warning labels may be provided solely electronically for all medical devices so long as (1) the electronic label is readily accessible to the device’s intended users, (2) intended users may request a paper label at no additional cost, and (3) the label affixed to the device or its packaging contains all information required under current laws and regulations.

The Food and Drug Administration may issue regulations establishing additional requirements or exceptions to these provisions.

Current Status of Bill HR 1539

Bill HR 1539 is currently in the status of Bill Introduced since February 24, 2025. Bill HR 1539 was introduced during Congress 119 and was introduced to the House on February 24, 2025. Bill HR 1539's most recent activity was Referred to the House Committee on Energy and Commerce. as of February 24, 2025

Bipartisan Support of Bill HR 1539

Total Number of Sponsors

Democrat Sponsors

Republican Sponsors

Unaffiliated Sponsors

Total Number of Cosponsors

Democrat Cosponsors

Republican Cosponsors

Unaffiliated Cosponsors

Policy Area and Potential Impact of Bill HR 1539

Primary Policy Focus

Health

Alternate Title(s) of Bill HR 1539

To amend the Federal Food, Drug, and Cosmetic Act to expand the types of devices for which required labeling may be made available solely by electronic means, and for other purposes.

Comments

August Deal

685

11 months ago

I think this bill is good for us. It will help with the labeling of medical devices. I think it's important for us to know what we are using. This bill will make it easier for us to understand what we are putting in our bodies. I support this bill and think it will be good for everyone.